Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats

被引:35
作者
Ahmad, S [1 ]
Fowler, LJ [1 ]
Whitton, PS [1 ]
机构
[1] Univ London Sch Pharm, Dept Pharmacol, London WC1N 1AX, England
关键词
lamotrigine; amino acid; hippocampus; microdialysis;
D O I
10.1016/j.brainres.2004.09.016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The antiepileptic drug lamotrigine (LTG) is a relatively novel anticonvulsant frequently used in polytherapy and increasingly in monotherapy. LTG is believed to act by reducing excitatory glutamate (GLU) release due to an inhibition of Na+ channels. In the present study, we have investigated the effects of acute and chronic (up to 21 days) treatment with LTG on basal and either veratridine- or KCl-stimulated release of aspartate (ASP), GLU, taurine (TAU) and GABA in the hippocampus of freely moving rats using microdialysis. Additionally, we have measured LTG concentrations in the plasma, whole brain and extracellular fluid of rats at the same time points. LTG significantly reduced basal ASP and GLU but only at the highest dose used (20 mg/kg) and was entirely without effect on basal TAU or GABA. When either veratridine or 100 mM KCl were added to the infusion medium amino acid release was evoked although the extent of this varied from one amino acid to another. LTG (10 mg/kg) reduced veratridine-evoked release of all four amino acids studied, although this was most marked in the case of GLU. LTG had no effect on KCl-stimulated amino acid release. When given for up to 21 days (2 X 5 mg/kg/day), LTG had no effect on basal amino acid levels. In contrast, LTG demonstrated over the time period studied an increasingly inhibitory effect on veratridine-evoked amino acid release. This effect of the drug was proportionally much greater in the case of GLU than for the other three amino acids studied. Measurement of plasma, whole brain tissue and extracellular LTG showed that in each of these compartments, it had reached an apparent steady state within 4 days of commencement of treatment and appeared to mirror the neurochemical changes measured. Our estimate of plasma LTG indicates that during chronic study, this was well within the therapeutic range, suggesting that the current neurochemical observations are clinically relevant. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:41 / 47
页数:7
相关论文
共 37 条
[1]   Lamotrigine and carbamazepine affect differently the release of D-[3H]Aspartate from mouse cerebral cortex slices:: Involvement of NO [J].
Afanas'ev, I ;
Kudrin, V ;
Rayevsky, KS ;
Varga, V ;
Saransaari, P ;
Oja, SS .
NEUROCHEMICAL RESEARCH, 1999, 24 (09) :1153-1159
[2]   Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat [J].
Ahmad, S ;
Fowler, LJ ;
Whitton, PS .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (01) :136-142
[3]  
AHMAD S, 1995, BR PHARM SOC, V115
[4]   Lamotrigine inhibits extracellular glutamate accumulation during transient global cerebral ischemia in rabbits [J].
Bacher, A ;
Zornow, MH .
ANESTHESIOLOGY, 1997, 86 (02) :459-463
[5]   New antiepileptic drugs [J].
Bazil, CW .
NEUROLOGIST, 2002, 8 (02) :71-81
[6]  
BIGGS CS, 1994, J NEUROCHEM, V63, P2197
[7]   A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder [J].
Bowden, CL ;
Calabrese, JR ;
Sachs, G ;
Yatham, LN ;
Asghar, SA ;
Hompland, M ;
Montgomery, P ;
Earl, N ;
Smoot, TM ;
DeVeaugh-Geiss, J .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (04) :392-400
[8]   Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala:: implications for its effects in seizure and affective disorders [J].
Braga, MFM ;
Aroniadou-Anderjaska, V ;
Post, RM ;
Li, H .
NEUROPHARMACOLOGY, 2002, 42 (04) :522-529
[9]   A comparison of the effects of lamotrigine on neuroma-induced action potential firing and normal behaviour in rat: implications for establishing a pre-clinical 'therapeutic index' [J].
Butler, P ;
Gardiner, JC ;
Loftus, JP ;
Karran, E ;
Roffey, SJ ;
Gupta, P ;
Pryke, JG .
NEUROSCIENCE LETTERS, 2001, 304 (1-2) :13-16
[10]   Synergistic interaction between valproate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice [J].
Cuadrado, A ;
de las Cuevas, I ;
Valdizán, EM ;
Armijo, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 453 (01) :43-52